(Q44076053)

29 November 2017

0 references

Effectiveness and safety of bemiparin versus low-molecular weight heparins in orthopaedic surgery (English)

1 reference

29 November 2017

Ferriols-Lisart R

1

1 reference

29 November 2017

Ferriols-Lisart F

series ordinal

2

1 reference

29 November 2017

Jiménez-Torres V

series ordinal

3

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

International Journal of Clinical Pharmacy

29 November 2017

published in

1 reference

29 November 2017

volume

24

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

87-94

1 reference

Pharmacokinetics and tolerability of a new low molecular mass heparin (RO-11) in healthy volunteers--a dose-finding study within the therapeutical range

29 November 2017

cites work

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Comparison of antithrombotic efficacy and haemorrhagic side-effects of Clivarin versus enoxaparin in patients undergoing total hip replacement surgery

1 reference

12 December 2020

Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.

1 reference

12 December 2020

Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin

1 reference

12 December 2020

Prevention of deep vein thrombosis after major knee surgery--a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo

1 reference

12 December 2020

Prophylaxis of postoperative thromboembolism with low molecular weight heparins.

1 reference

12 December 2020

Low-molecular-weight heparins

1 reference

12 December 2020

Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement

1 reference

12 December 2020

Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty

1 reference

12 December 2020

Thromboprophylaxis by low-molecular-weight heparin in elective hip surgery. A placebo controlled study

1 reference

12 December 2020

Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement

1 reference

12 December 2020

The thromboprophylactic effect of a low-molecular-weight heparin (Fragmin) in hip fracture surgery. A placebo-controlled study

1 reference

12 December 2020

Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo

1 reference

12 December 2020

A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group

1 reference

12 December 2020

Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin.

1 reference

12 December 2020

[Comparison of the efficacy and tolerance of Kabi 2165 and standard heparin in the prevention of deep venous thrombosis in total hip prosthesis]

1 reference

12 December 2020

Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement

1 reference

12 December 2020

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

1 reference

12 December 2020

A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture

1 reference

12 December 2020

Clinical trials with low molecular weight heparins in the prevention of postoperative thromboembolic complications: a meta-analysis

1 reference

12 December 2020

Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group

1 reference

12 December 2020

Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecular-weight heparin.

1 reference

12 December 2020

Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin

1 reference

12 December 2020

Bias in meta-analytic research

1 reference

12 December 2020

Pharmacology of the low-molecular-weight heparins.

1 reference

12 December 2020

Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses

1 reference

12 December 2020

Cost-effectiveness of the low molecular weight heparin reviparin sodium in thromboprophylaxis

1 reference

12 December 2020

Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement

1 reference

12 December 2020

Survey of prophylaxis against venous thromboembolism in adults undergoing hip surgery.

1 reference

12 December 2020

A method for meta-analysis of epidemiological studies

1 reference

12 December 2020

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

1 reference

12 December 2020

A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation

1 reference

12 December 2020

Efficacy and safety of Clivarin and other LMWHs in general surgery: a meta-analysis.

1 reference

12 December 2020

Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamine

1 reference

12 December 2020

Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement

1 reference

12 December 2020

Are the available low-molecular-weight heparin preparations the same?

1 reference

12 December 2020

Low molecular weight heparin: a critical analysis of clinical trials

1 reference

12 December 2020

European consensus statement on the prevention of venous thromboembolism. European Consensus Conference, Windsor, U.K., November, 1991.

1 reference

12 December 2020

Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary

1 reference

12 December 2020

Preclinical studies on a low molecular weight heparin

1 reference

12 December 2020

Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery

1 reference

12 December 2020

Heparin/low molecular weight heparin and tissue factor pathway inhibitor

1 reference

12 December 2020

Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures.

1 reference

12 December 2020

Kinetic behaviour of the TFPI and anti-FXa effects, after the injection of a LMWH (RO-11) in healthy subjects

1 reference

12 December 2020

Once-daily dosing of enoxaparin (a low molecular weight heparin) in prevention of deep vein thrombosis after total hip replacement

1 reference

12 December 2020

Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery

1 reference

12 December 2020

Bioavailability and pharmacokinetics of a new low molecular weight heparin (RO-11)--a three way cross-over study in healthy volunteers

1 reference

12 December 2020

The use of low molecular weight heparins for postsurgical deep vein thrombosis prevention in orthopaedic patients

1 reference

12 December 2020

Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine

1 reference

12 December 2020

Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study Group

1 reference

12 December 2020

Low molecular weight versus unfractionated heparin. A clinical and economic appraisal

1 reference

12 December 2020

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

1 reference

12 December 2020

Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery: a meta-analysis of randomised clinical trials

1 reference

12 December 2020

Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin

1 reference

12 December 2020

Meta-analysis: quantitative integration of independent research results

1 reference

12 December 2020

Thrombosis prophylaxis with low molecular weight heparin in total hip replacement

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1016187426582

1 reference

29 November 2017

1 reference